Long Term Progression-Free Survival in a Patient with Locally Advanced Prostate Cancer under Low Dose Intermittent Androgen Deprivation Therapy with Bicalutamide Only

Androgen deprivation is a common treatment option in patients with locally advanced or metastatic prostate cancer. No case of long term treatment with an intermittent approach with only low dose bicalutamide (50 mg daily) has been described yet. We report a 60-year-old patient, initially presenting...

Descripción completa

Detalles Bibliográficos
Autores principales: Latz, Stefan, Fisang, Christian, Ebert, Wolfram, Orth, Stefan, Engehausen, Dirk G., Müller, Stefan C., Anding, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391157/
https://www.ncbi.nlm.nih.gov/pubmed/25883827
http://dx.doi.org/10.1155/2015/928787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391157/
https://www.ncbi.nlm.nih.gov/pubmed/25883827
http://dx.doi.org/10.1155/2015/928787

Ejemplares similares